- Home
- Services
- Physical Parameter Testing
- Solubility and Solution Behavior Analysis
- Maximum Solubility Determination
Maximum Solubility Determination is a critical physicochemical test to quantify the saturation concentration of a drug substance in a specified solvent system under defined conditions. This parameter is essential for formulation development, bioavailability prediction, and regulatory compliance.
Maximum Solubility
Maximum solubility refers to the highest concentration of a solute (e.g., an active pharmaceutical ingredient, API) that can dissolve in a specific solvent system under equilibrium conditions at a defined temperature, pH, and pressure. It represents the thermodynamic limit at which the solute-solvent interactions stabilize the dissolved phase, and any additional solute will remain undissolved as a precipitate. In pharmaceutical sciences, this parameter is foundational for:
- Formulation Design: Selecting solvents, co-solvents, or surfactants to enhance drug delivery.
- Bioavailability Prediction: Poor solubility (<1 mg/mL) often correlates with low oral absorption (BCS Class II/IV).
- Stability Assessment: Preventing crystallization in liquid formulations (e.g., injectables, syrups).
- Regulatory Compliance: Meeting USP/ICH guidelines for solubility characterization.
Understanding and optimizing maximum solubility is pivotal in overcoming drug development challenges, particularly for poorly water-soluble molecules, which constitute >70% of pipeline candidates. Modern techniques (e.g., nanomilling, amorphous solid dispersions) aim to push solubility beyond intrinsic limits to achieve therapeutic efficacy.
Methodology
1. Experimental Design
-
Solvent Systems:
- Aqueous buffers (pH 1.2–7.4, simulating physiological conditions).
- Organic solvents (e.g., ethanol, PEG, propylene glycol).
- Surfactant-containing media (e.g., polysorbate 80, SDS).
-
Temperature Control:
- Standard: 25°C ± 0.5°C (ambient) or 37°C ± 0.5°C (physiological).
-
Equilibration Time:
- 24–72 hours with agitation (orbital shaker) to reach equilibrium.
2. USP-Compliant Techniques
-
Shake-Flask Method (USP <1176>):
- Excess API is added to the solvent.
- Agitated until equilibrium; supernatant filtered (0.45 µm/0.22 µm membrane).
- Quantification via HPLC/UV-Vis spectrophotometry.
-
Dynamic Light Scattering (DLS):
- Monitors particle size changes to detect undissolved solids.
-
Isothermal Titration Calorimetry (ITC):
- Measures heat changes during dissolution to determine saturation points.
3. Data Analysis
-
Solubility Calculation:
- Cmax = Mass of dissolved solute (g) / Volume of solvent (L)
-
Validation Criteria:
- Repeatability (RSD ≤ 5%).
- Correlation with theoretical solubility (e.g., Henderson-Hasselbalch equation for ionizable compounds).
4. Reporting Deliverables
-
Comprehensive Report Includes:
- Experimental conditions (solvent, temperature, equilibration time).
- Analytical method validation summary.
- Solubility curve (concentration vs. solvent composition/pH).
- Comparison with pharmacopeial standards (USP/EP).
Regulatory Considerations
- USP <1176>: Defines solubility categories (e.g., "freely soluble," "sparingly soluble") and methodology.
- ICH Q6A: Requires solubility data for decision trees on dissolution specifications.
- FDA Guidance for Industry: Emphasizes biorelevant media (e.g., FaSSIF/FeSSIF) for BCS classification.
Partner With Us
- Regulatory Expertise: Full compliance with USP, ICH, and FDA guidelines.
- Advanced Technology: State-of-the-art HPLC, DLS, and automated systems.
- Custom Solutions: Tailored experimental designs for novel formulations (e.g., lipid-based, nanoemulsions).
For more information on our Maximum Solubility Determination service or to discuss your specific requirements, please contact us today.